PDSB PDS Biotechnology Corp
Nasdaq · SEC CIK 1472091 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 57 since 2021-10-20, latest 2026-03-03
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 6
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-28 | PDSB | Glover Stephen C. | Dir | P - Purchase | $1.66 | +15.1K | 78.9K | +24% | +$25.0K |
| D | 2025-03-03 | 2025-02-28 | PDSB | Freitag Gregory Gene | Dir | P - Purchase | $1.66 | +15.1K | 61.2K | +33% | +$25.0K |
| D | 2022-12-02 | 2022-12-02 | PDSB | BEDU-ADDO FRANK | Pres, CEO, Dir | F - Tax | $9.78 | -175.2K | 690.9K | -20% | -$1.71M |
| D | 2022-12-02 | 2022-12-02 | PDSB | BEDU-ADDO FRANK | Pres, CEO, Dir | M - OptEx | $6.57 | +219.5K | 866.0K | +34% | +$1.44M |
| M | 2021-12-14 | 2021-12-13 | PDSB | HILL MATTHEW C | CFO | P - Purchase | $8.99 | +2,900 | 3,875 | +297% | +$26.1K |
| MI | 2021-12-14 | 2021-12-13 | PDSB | HILL MATTHEW C | CFO | P - Purchase | $9.00 | +200 | 3,975 | +5% | +$1,800 |
Purchase Sale Sale after option exercise All abbreviations